Krystal Biotech, Inc. (KRYS)

272.20 +10.40 (+3.97%) USD  |  NASDAQ  |  Feb 23, 14:42
More

Krystal Biotech EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Estimates for Current Quarter Range, Past 5 Years

View EBITDA Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Estimates for Current Quarter Benchmarks

View EBITDA Estimates for Current Quarter Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
DexCom, Inc. Upgrade
Alkermes Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade